Tredje AP-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.4M	Buy	49,594 +9,147	+23%	+$3.11M	0.09%	216
2025 Q4	$16.1M	Buy	40,447 +26,991	+201%	+$11.9M	0.12%	128
2025 Q3	$6.14M	Buy	13,456 +1,254	+10%	+$511K	0.05%	145
2025 Q2	$3.98M	Sell	12,202 -3,705	-23%	-$1.03M	0.03%	151
2025 Q1	$4.3M	Buy	15,907 +6,165	+63%	+$1.58M	0.04%	161
2024 Q4	$2.29M	Sell	9,742 -9,741	-50%	-$2.56M	0.02%	247
2024 Q3	$5.36M	Hold	19,483	–	–	0.05%	198
2024 Q2	$4.73M	Sell	19,483 -308	-2%	-$48.6K	0.05%	190
2024 Q1	$2.96M	Hold	19,791	–	–	0.03%	288
2023 Q4	$3.79M	Sell	19,791 -765	-4%	-$130K	0.05%	239
2023 Q3	$3.64M	Sell	20,556 -1,812	-8%	-$346K	0.05%	230
2023 Q2	$4.25M	Sell	22,368 -3,720	-14%	-$738K	0.06%	219
2023 Q1	$5.23M	Buy	26,088 +1,824	+8%	+$383K	0.08%	175
2022 Q4	$5.77M	Buy	24,264 +422	+2%	+$90K	0.1%	154
2022 Q3	$4.77M	Buy	+23,842	New	+$4.55M	0.1%	154
2018 Q2	–	Sell	-7,200	Closed	-$858K	–	400
2018 Q1	$858K	Buy	7,200 +3,550	+97%	+$458K	0.03%	444
2017 Q4	$464K	Buy	+3,650	New	+$459K	0.02%	516